183 related articles for article (PubMed ID: 36359788)
1. KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 Signalling.
Li F; Peng J; Feng H; Yang Y; Gao J; Liu C; Xu J; Zhao Y; Pan S; Wang Y; Xu L; Qian W; Zong J
Cells; 2022 Oct; 11(21):. PubMed ID: 36359788
[TBL] [Abstract][Full Text] [Related]
2. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
[TBL] [Abstract][Full Text] [Related]
3. Never in mitosis gene A-related kinase-6 deficiency deteriorates diabetic cardiomyopathy via regulating heat shock protein 72.
Shao S; Xiao L; Jia M; Zhang C; Zhao G; Yao R; Wang X; Gao L
J Mol Med (Berl); 2023 Apr; 101(4):419-430. PubMed ID: 36867206
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
5. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition.
Wu QQ; Liu C; Cai Z; Xie Q; Hu T; Duan M; Wu H; Yuan Y; Tang Q
Cell Death Dis; 2020 Mar; 11(3):160. PubMed ID: 32123163
[TBL] [Abstract][Full Text] [Related]
7. Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress.
Li G; Yang L; Feng L; Yang J; Li Y; An J; Li D; Xu Y; Gao Y; Li J; Liu J; Yang L; Qi Z
Mol Nutr Food Res; 2020 Sep; 64(18):e2000231. PubMed ID: 32729956
[TBL] [Abstract][Full Text] [Related]
8. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
Kyriazis ID; Hoffman M; Gaignebet L; Lucchese AM; Markopoulou E; Palioura D; Wang C; Bannister TD; Christofidou-Solomidou M; Oka SI; Sadoshima J; Koch WJ; Goldberg IJ; Yang VW; Bialkowska AB; Kararigas G; Drosatos K
Circ Res; 2021 Feb; 128(3):335-357. PubMed ID: 33539225
[TBL] [Abstract][Full Text] [Related]
9. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
10. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
12. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
[TBL] [Abstract][Full Text] [Related]
13. TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy.
Xiao Y; Wu QQ; Duan MX; Liu C; Yuan Y; Yang Z; Liao HH; Fan D; Tang QZ
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1728-1743. PubMed ID: 29476905
[TBL] [Abstract][Full Text] [Related]
14. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
Tang Q; Len Q; Liu Z; Wang W
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
[TBL] [Abstract][Full Text] [Related]
16. Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects.
Li R; Liu Y; Shan YG; Gao L; Wang F; Qiu CG
Oxid Med Cell Longev; 2019; 2019():3206542. PubMed ID: 31354905
[TBL] [Abstract][Full Text] [Related]
17. A study of the effects of SGLT-2 inhibitors on diabetic cardiomyopathy through miR-30d/KLF9/VEGFA pathway.
Zhang WY; Wang J; Li AZ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6346-6359. PubMed ID: 32572932
[TBL] [Abstract][Full Text] [Related]
18. Quercetin Inhibits Pyroptosis in Diabetic Cardiomyopathy through the Nrf2 Pathway.
Wei Z; Jing Z; Pinfang K; Chao S; Shaohuan Q
J Diabetes Res; 2022; 2022():9723632. PubMed ID: 36624860
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
Yang G; Zhang Q; Dong C; Hou G; Li J; Jiang X; Xin Y
J Cell Physiol; 2024 Feb; 239(2):e31149. PubMed ID: 38308838
[TBL] [Abstract][Full Text] [Related]
20. Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.
Bai Y; Cui W; Xin Y; Miao X; Barati MT; Zhang C; Chen Q; Tan Y; Cui T; Zheng Y; Cai L
J Mol Cell Cardiol; 2013 Apr; 57():82-95. PubMed ID: 23353773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
